Gabapentin
- Generic Name
- Gabapentin
- Brand Names
- Gralise, Neurontin
- Drug Type
- Small Molecule
- Chemical Formula
- C9H17NO2
- CAS Number
- 60142-96-3
- Unique Ingredient Identifier
- 6CW7F3G59X
- Background
Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...
- Indication
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...
- Associated Conditions
- Partial-Onset Seizures, Peripheral Neuropathic Pain, Postherpetic Neuralgia
- Associated Therapies
- -
Sphenopalatine Blockade Versus Clinical Treatment
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT04148846
- Locations
- 🇧🇷
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Cognitive Changes With Gabapentin Treatment
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2021-03-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 3
- Registration Number
- NCT04106011
- Locations
- 🇺🇸
Washington University Medical Center/Barnes-Jewish Hospital, Saint Louis, Missouri, United States
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin
- Conditions
- Interventions
- First Posted Date
- 2019-08-09
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Boston Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT04052139
- Locations
- 🇷🇺
First St. Petersburg Pavlov State Medical University, Saint Petersburg, Russian Federation
Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome
- Conditions
- Interventions
- First Posted Date
- 2019-07-18
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Francisco Unda Solano
- Target Recruit Count
- 80
- Registration Number
- NCT04025203
- Locations
- 🇻🇪
Ciudad Hospitalaria Enrique Tejera, Valencia, Carabobo, Venezuela
The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2019-07-01
- Lead Sponsor
- Rothman Institute Orthopaedics
- Target Recruit Count
- 216
- Registration Number
- NCT04003350
- Locations
- 🇺🇸
Rothman Institute, Philadelphia, Pennsylvania, United States
Gabapentin and Chronic Post Surgical Pain
- Conditions
- Interventions
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2021-02-08
- Lead Sponsor
- Emory University
- Registration Number
- NCT03867240
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 60
- Registration Number
- NCT03859024
- Locations
- 🇺🇸
University of Alabama of Birmingham, Birmingham, Alabama, United States
Gabapentin Pretreatment for Staged Bilateral Cataract Operations
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2020-11-12
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT03826615
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Nonopioid Analgesia After Labral Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 100
- Registration Number
- NCT03825809
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Nonopioid Analgesia After Arthroscopic Meniscus Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 61
- Registration Number
- NCT03820193
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.